In HPV+ tumours, p53 is kept inactive through E6-mediated proteasomal degradation,35 whereas HPV− HNSCCs often contain inactivating p53 mutations, resulting in a stabilised but non-functional protein. This evidence concerns the gene TP53 and neoplasm.